Medpace Holdings, Inc. is a leading global contract research organization that provides outsourced clinical development services to biotechnology pharmaceutical and medical device companies. The company generates revenue by offering a full suite of services that support the entire clinical development process from Phase I through IV across many therapeutic areas including oncology metabolic cardiology antiviral and anti infective and central nervous system research. It earns fees for activities such as study design site management patient recruitment...
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | WAT | Waters Corp /De/ | 27,360.50 Bn | 42.27 | 7,256.31 | 4.86 Bn |
| 2 | TMO | Thermo Fisher Scientific Inc. | 166.69 Bn | 24.59 | 3.69 | 43.16 Bn |
| 3 | DHR | Danaher Corp /De/ | 116.47 Bn | 31.82 | 4.70 | 18.48 Bn |
| 4 | IDXX | Idexx Laboratories Inc /De | 42.38 Bn | 38.84 | 9.53 | 0.83 Bn |
| 5 | A | Agilent Technologies, Inc. | 32.06 Bn | 24.90 | 4.54 | 0.30 Bn |
| 6 | IQV | Iqvia Holdings Inc. | 28.74 Bn | 20.99 | 1.73 | 15.83 Bn |
| 7 | NTRA | Natera, Inc. | 27.83 Bn | -121.42 | 11.13 | 0.02 Bn |
| 8 | ILMN | Illumina, Inc. | 21.92 Bn | 25.95 | 4.99 | 1.49 Bn |